A neoadjuvant approach to esophageal cancer

M. M. DeCamp*, D. J. Sugarbaker

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Patients with symptomatic esophageal cancer represent a significant challenge to the thoracic clinician, whether medical oncologist, surgeon, or radiation therapist. Historically, cure has been rare and palliation has been a more realistic goal. Surgery was often viewed as radical or risky as limited long-term survival was weighed against expected operative morbidity and mortality. Epidermoid tumors were minimally responsive to available chemotherapy. Primary radiotherapy achieved similar overall survival; however, recurrent dysphagia limited its palliative benefit.

Original languageEnglish (US)
Pages (from-to)216S-217S
JournalChest
Volume107
Issue number6 SUPPL.
DOIs
StatePublished - Jan 1 1995

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'A neoadjuvant approach to esophageal cancer'. Together they form a unique fingerprint.

  • Cite this

    DeCamp, M. M., & Sugarbaker, D. J. (1995). A neoadjuvant approach to esophageal cancer. Chest, 107(6 SUPPL.), 216S-217S. https://doi.org/10.1378/chest.107.6_Supplement.216S